New York Hematopathology Group Meeting 2024

Wednesday, October 23, 2024, 4:00 PM - 7:00 PM, Schwartz Cancer Research Building (Room S1132), New York, NY

Memorial Sloan Kettering Cancer Center and the New York Hematopathology Group present a complimentary three-hour event offering an update on hematologic malignancies and its importance in the practice of hematopathology. We're excited to announce our 2024 invited speakers:

Gabriel Griffin, MD
Dana-Farber Cancer Institute
Boston. MA

Megan Lim, MD, PhD
Memorial Sloan Kettering
New York, NY  

Registration for this meeting is complimentary for all participants. Attendees have the option to participate either in person or virtually. Please note this event will take place at Memorial Sloan Kettering's:

Schwartz Cancer Research Building
1250 First Avenue, Room S1132
New York, NY 10065

Get Directions

Light refreshments will be provided for those attending in person

1. Advance your understanding of science in hematologic malignancies

This event is complimentary for all participants. Please select the 'Register' tab above to complete registration.

IN-PERSON REGISTRANTS: Light refreshments will be provided. Please contact [email protected] at least one week prior to this meeting if you have any special dietary requests or require any specific accommodations for joining us onsite.

VIRTUAL REGISTRANTS: For those who wish to join this meeting virtually, access details, including the Zoom link, will be in the confirmation email you receive after your registration is complete. The information can also be found in your account on msk.org/cme under 'MY CME' and 'Registrations & Receipts'.

If you register for this program and are no longer able to attend, please email [email protected].

Memorial Sloan Kettering Cancer Center (MSK) reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from [email protected]. MSK is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Memorial Sloan Kettering Cancer Center and New York Hematopathology Group. The Memorial Sloan Kettering Cancer Center is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for course attendees.

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Wednesday, October 23, 2024